Identification of a novel homozygous frameshift mutation in SLC29A3 gene in a case with H syndrome from Iran.

[1]  S. Guthery,et al.  H syndrome: 5 new cases from the United States with novel features and responses to therapy , 2017, Pediatric Rheumatology.

[2]  A. Dashti,et al.  A Child With H Syndrome , 2016 .

[3]  A. Zlotogorski,et al.  H syndrome--four new patients from India. , 2014, Indian journal of dermatology, venereology and leprology.

[4]  Y. Ramot,et al.  H syndrome: the first 79 patients. , 2014, Journal of the American Academy of Dermatology.

[5]  V. Negi,et al.  H syndrome with a novel homozygous R134C mutation in SLC29A3 gene , 2013, International journal of dermatology.

[6]  N. Kannan,et al.  Human Equilibrative Nucleoside Transporter-3 (hENT3) Spectrum Disorder Mutations Impair Nucleoside Transport, Protein Localization, and Stability* , 2010, The Journal of Biological Chemistry.

[7]  P. Devilee,et al.  Mutations in SLC29A3, Encoding an Equilibrative Nucleoside Transporter ENT3, Cause a Familial Histiocytosis Syndrome (Faisalabad Histiocytosis) and Familial Rosai-Dorfman Disease , 2010, PLoS genetics.

[8]  C. Chiaverini,et al.  The H syndrome: two novel mutations affecting the same amino acid residue of hENT3. , 2010, Journal of dermatological science.

[9]  R. Hennekam,et al.  SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway. , 2009, Human molecular genetics.

[10]  L. Sun,et al.  Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  B. Glaser,et al.  The H syndrome: a genodermatosis characterized by indurated, hyperpigmented, and hypertrichotic skin with systemic manifestations. , 2008, Journal of the American Academy of Dermatology.